ProfileGDS5678 / 1455542_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 32% 33% 33% 33% 33% 33% 32% 33% 33% 34% 33% 32% 33% 33% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.7706832
GSM967853U87-EV human glioblastoma xenograft - Control 22.7526733
GSM967854U87-EV human glioblastoma xenograft - Control 32.7498233
GSM967855U87-EV human glioblastoma xenograft - Control 42.7050133
GSM967856U87-EV human glioblastoma xenograft - Control 52.7095633
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.8168733
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.7802532
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.7343533
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.7330233
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.7486434
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.7385533
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.6899432
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.7515933
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.7464333